Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Kindly do not exceed from the recommended daily dose
Weight regain is possible if you return to previous eating patterns
Evidence for mitochondrial uptake of glutathione by dicarboxylate and 2-oxoglutarate carriers
The SELECT trial demonstrated that, in people with established cardiovascular disease, semaglutide 2.4 mg reduced major cardiovascular events by 20% on top of background statin therapy
These new analyses build on the growing body of clinical evidence for semaglutide, an important medicine that has already been extensively studied not only in obesity but also in cardiovascular disease and metabolic dysfunction-associated steatohepatitis (MASH), says Andrea Traina, PharmD, senior medical director, obesity and liver health, Novo Nordisk, in a release
Wegovy (semaglutide) is one of the most clinically studied and effective weight loss medications currently available
US$ 28.34
US$ 24.87
US$ 21.01
US$ 21.31
US$ 25.12
